Copyright Notice
Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
Bookshelf ID: NBK594293PMID: 37603680
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 1262780-97-1
Drug Levels and Effects
Summary of Use during Lactation
No information is available on etelcalcetide during breastfeeding. Because etelcalcetide is a large molecule with a molecular weight of 1047.5 Da, the amount in milk is likely to be low. The manufacturer recommends that breastfeeding be avoided during use. An alternate drug may be preferred, especially while nursing a newborn or preterm infant.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
Substance Identification
Substance Name
Etelcalcetide
CAS Registry Number
1262780-97-1
Drug Class
Breast Feeding
Lactation
Milk, Human
Calcium-Regulating Hormones and Agents
Calcimimetic Agents
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- Pharmacology of Parsabiv(®) (etelcalcetide, ONO-5163/AMG 416), a novel allosteric modulator of the calcium-sensing receptor, for secondary hyperparathyroidism in hemodialysis patients.[Eur J Pharmacol. 2019]Pharmacology of Parsabiv(®) (etelcalcetide, ONO-5163/AMG 416), a novel allosteric modulator of the calcium-sensing receptor, for secondary hyperparathyroidism in hemodialysis patients.Harada K, Fujioka A, Konno M, Inoue A, Yamada H, Hirota Y. Eur J Pharmacol. 2019 Jan 5; 842:139-145. Epub 2018 Oct 19.
- Review Peginesatide.[Drugs and Lactation Database (...]Review Peginesatide.. Drugs and Lactation Database (LactMed®). 2006
- Review Pramlintide.[Drugs and Lactation Database (...]Review Pramlintide.. Drugs and Lactation Database (LactMed®). 2006
- Review Bremelanotide.[Drugs and Lactation Database (...]Review Bremelanotide.. Drugs and Lactation Database (LactMed®). 2006
- Review Brodalumab.[Drugs and Lactation Database (...]Review Brodalumab.. Drugs and Lactation Database (LactMed®). 2006
- Etelcalcetide - Drugs and Lactation Database (LactMed®)Etelcalcetide - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...